Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer.
about
Antiestrogens: structure-activity relationships and use in breast cancer treatmentThe hunt for a selective 17,20 lyase inhibitor; learning lessons from nature.Aptamer-Enabled Manipulation of the Hsp70 Chaperone System Suggests a Novel Strategy for Targeted Ubiquitination.New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells.Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.Recent development of targeted approaches for the treatment of breast cancer.Targeted protein knockdown using small molecule degraders.Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancersCopper- or Thermally Induced Divergent Outcomes: Synthesis of 4-Methyl 2H-Chromenes and Spiro-4H-Pyrazoles.Identification of differentially expressed three novel transcript variants of mouse ARNT gene.Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.
P2860
Q28077245-A9F0F28D-59C6-47FF-AF7C-953B3B35124FQ34525556-DA3EA51F-7C2E-487F-A27D-2AD202CDCD9CQ36580076-BCE41EAC-A5F7-4B83-ABA7-C2593B495611Q37300127-B6EF9852-E912-483A-85A8-1B333F85DCB9Q38430208-F1DAE8EF-397A-406C-B16A-1475BFA77A55Q38719706-B33465BE-E934-409C-8557-5E6F38160F3DQ38802191-D6F0E2FE-FAB8-4A14-BBED-FAC3383E84CFQ39367115-0A38B582-9296-46FF-BDD5-33D4748087BCQ41305086-37601117-06DD-4E33-8DEB-19F256DCFF50Q47374960-9DD372DF-8CE5-4D93-B831-C39D08A42F1CQ51561948-F486287F-9536-4AC1-A67D-7B900E84E2CEQ53564161-31EC9570-FDF2-4C2D-963A-3983D771F825
P2860
Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Oral Selective Estrogen Recept ...... ine Therapy for Breast Cancer.
@ast
Oral Selective Estrogen Recept ...... ine Therapy for Breast Cancer.
@en
type
label
Oral Selective Estrogen Recept ...... ine Therapy for Breast Cancer.
@ast
Oral Selective Estrogen Recept ...... ine Therapy for Breast Cancer.
@en
prefLabel
Oral Selective Estrogen Recept ...... ine Therapy for Breast Cancer.
@ast
Oral Selective Estrogen Recept ...... ine Therapy for Breast Cancer.
@en
P2093
P2860
P1476
Oral Selective Estrogen Recept ...... ine Therapy for Breast Cancer.
@en
P2093
Donald P McDonnell
John D Norris
Suzanne E Wardell
P2860
P304
P356
10.1021/ACS.JMEDCHEM.5B00760
P407
P577
2015-06-03T00:00:00Z